Observe Medical - Director's Dealing 2020

Observe Medical ASA - Primary insider notice

Reference is made to the ongoing rights issue of 4,090,909 new shares to a

subscription price of NOK 11.00 (the "Offer Shares") in Observe Medical ASA (the

"Company") as announced in the Company's stock exchange announcement on 19 June

2020 (the "Rights Issue").

Navamedic ASA ("NAVA"), represented at the Company's board of directors by

Kathrine Gamborg Andreassen, has today, on 25 June 2020, in total subscribed for

1,022,727 Offer Shares of which 853,235 Offer Shares were subscribed through the

exercise of subscription rights and 169,492 Offer Shares were over-subscribed.

Subject to NAVA receiving full allocation for its subscription of Offer Shares

pursuant to the allocation criteria for the Rights Issue, NAVA, with its related

parties, will own 4,222,727 shares in the Company, equal to approximately 21.73%

of the outstanding shares in the Company following completion of the Rights

Issue.

This information is subject to disclosure requirements pursuant to section 4-2

of the Norwegian Securities Trading Act.

AI assistant